[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=NEO #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]

NEO — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

10.35

Margin Of Safety %

Put/Call OI Ratio

0.09

EPS Next Q Diff

0.04

EPS Last/This Y

0.08

EPS This/Next Y

0.11

Price

16.83

Target Price

23.4

Analyst Recom

1.36

Performance Q

2.68

Upside

-152.0%

Beta

1.83

Ticker: NEO

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-13	NEO	16.66	0.05	2.17	15434
2026-10-14	NEO	16.87	0.09	0.97	16095
2026-10-15	NEO	17.24	0.09	0.00	16135
2026-10-16	NEO	16.66	0.08	0.04	16907
2026-10-19	NEO	16.44	0.08	0.06	16536
2026-10-20	NEO	16.61	0.08	0.10	16552
2026-10-21	NEO	17.03	0.08	0.31	16567
2026-10-22	NEO	16.38	0.08	0.00	16601
2026-10-23	NEO	16.59	0.08	0.03	16584
2026-10-26	NEO	16.69	0.08	0.00	16583
2026-10-27	NEO	17.27	0.08	0.59	16677
2026-10-28	NEO	17.99	0.09	0.11	16682
2026-10-29	NEO	17.92	0.09	2.67	16693
2026-10-30	NEO	17.38	0.08	0.67	16677
2026-11-02	NEO	16.45	0.08	0.64	16681
2026-11-03	NEO	16.84	0.08	1.15	16670
2026-11-04	NEO	17.14	0.09	0.35	16700
2026-11-05	NEO	16.5	0.09	0.88	16704
2026-11-06	NEO	16.84	0.09	0.02	16708
2026-11-09	NEO	17.59	0.09	0.25	16718
2026-11-10	NEO	16.97	0.09	0.00	16729
2026-11-11	NEO	16.83	0.09	0.76	16733
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-13	NEO	16.66	81.8	-	0.19
2026-10-14	NEO	16.87	84.8	-	0.19
2026-10-15	NEO	17.24	84.8	-	0.19
2026-10-16	NEO	16.66	84.8	-	0.19
2026-10-19	NEO	16.43	84.8	-	0.19
2026-10-20	NEO	16.43	84.8	-	0.19
2026-10-21	NEO	16.61	84.8	-	0.19
2026-10-22	NEO	16.39	84.8	-	0.19
2026-10-23	NEO	16.58	84.8	-	0.19
2026-10-26	NEO	16.69	84.8	-	0.19
2026-10-27	NEO	17.27	84.8	-	0.19
2026-10-28	NEO	18.00	84.8	-	0.19
2026-10-29	NEO	17.91	84.8	-	0.19
2026-10-30	NEO	17.37	84.8	-	0.19
2026-11-02	NEO	16.49	11.1	-	0.20
2026-11-03	NEO	16.84	12.1	-	0.20
2026-11-04	NEO	17.14	7.6	-	0.20
2026-11-05	NEO	16.50	7.6	-	0.20
2026-11-06	NEO	16.84	7.6	-	0.20
2026-11-09	NEO	17.59	7.6	-	0.20
2026-11-10	NEO	16.97	7.6	-	0.20
2026-11-11	NEO	16.83	7.6	-	0.20
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-13	NEO	-1.22	10.47	11.23
2026-10-14	NEO	-1.22	10.47	11.23
2026-10-15	NEO	-1.22	10.47	11.23
2026-10-16	NEO	-1.22	10.47	11.23
2026-10-19	NEO	-1.22	10.48	11.23
2026-10-20	NEO	-1.22	10.48	11.23
2026-10-21	NEO	-1.22	10.48	11.23
2026-10-22	NEO	-1.22	10.48	11.23
2026-10-23	NEO	-1.22	10.48	11.23
2026-10-26	NEO	-1.22	10.47	11.23
2026-10-27	NEO	-1.22	10.47	11.28
2026-10-28	NEO	-1.22	10.47	11.28
2026-10-29	NEO	-1.22	10.47	11.28
2026-10-30	NEO	-1.22	10.47	11.28
2026-11-02	NEO	-1.21	10.76	11.20
2026-11-03	NEO	-1.21	10.76	11.20
2026-11-05	NEO	-1.21	10.76	11.20
2026-11-06	NEO	-1.21	10.76	11.20
2026-11-09	NEO	-1.21	10.55	11.20
2026-11-10	NEO	-1.21	10.55	11.20
2026-11-11	NEO	-1.21	10.55	10.35
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=NEO 589 360 ]

Last Quarter Act. EPS

0.01

Avg. EPS Est. Current Quarter

0.06

Avg. EPS Est. Next Quarter

0.05

Insider Transactions

-1.21

Institutional Transactions

10.55

Beta

1.83

Average Sales Estimate Current Quarter

210

Average Sales Estimate Next Quarter

206

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

61.1

Max Drawdown 5-Year %

-88.7

Target Price

23.4

P/E

Forward P/E

53.77

PEG

1.08

P/S

2.76

P/B

2.71

P/Free Cash Flow

EPS

-0.25

Average EPS Est. Cur. Y

0.2

EPS Next Y. (Est.)

0.31

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-4.1

Relative Volume

0.48

Return on Equity vs Sector %

-30.4

Return on Equity vs Industry %

-15.7

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=NEO 589 450 ]

[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=NEO 589 450 ]

◆ NEO Healthcare

$16.83

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

14/20

Pullback

17/25

Volume

11/15

Valuation

12/20

TP/AR

4/10

Options

8/10

RSI

47.7

Range 1M

41.9%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WATCH

Momentum

9/25

Growth

28/30

Estimates

6/20

Inst/Vol

7/15

Options

6/10

EPS Yr

70%

EPS NY

53.4%

52W%

74.6%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -14.2% upside

Quality

5/30

Valuation

2/30

Growth

21/25

Stability

7/10

LT Trend

0/5

Upside

-14.2%

Quality

NEO — P/E HistoricalDiagnostics & Research

NeoGenomics, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 2500

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. The company was founded in 2001 and is headquartered in Fort Myers, Florida.

[News_NEO _Stock]

stock quote shares NEO – NeoGenomics, Inc. Stock Price stock today

news today NEO – NeoGenomics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch NEO – NeoGenomics, Inc. yahoo finance google finance

stock history NEO – NeoGenomics, Inc. invest stock market

stock prices NEO premarket after hours

ticker NEO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: NEO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y